Dysregulation of Sirtuin 2 (SIRT2) and Histone H3K18 Acetylation Pathways Associates With Adverse Prostate Cancer Outcomes

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3853-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sirtuin 2 (SIRT2)

Science-Business eXchange
2012English

Highly Potent Inhibitors of Sirtuin 1 (SIRT1), SIRT2 and SIRT3

Science-Business eXchange
2013English

Elevated Fecal Calprotectin Associates With Adverse Outcomes fromClostridium Difficileinfection in Older Adults

Infectious Diseases
MedicineInfectious DiseasesImmunologyMicrobiologyMicrobiology
2016English

Activation of P300 Histone Acetyltransferase Activity and Acetylation of the Androgen Receptor by Bombesin in Prostate Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Clinical and Therapeutic Implications of Histone Acetylation in Breast Cancer

West Indian Medical Journal
Medicine
2015English

Linking Obesogenic Dysregulation to Prostate Cancer Progression

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Molecular Pathways: Emerging Roles of Mammalian Sirtuin SIRT7 in Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Modulation of P53 C-Terminal Acetylation by Mdm2, P14ARF, and Cytoplasmic SirT2

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Living With Early Prostate Cancer: Decisions and Outcomes

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy